BCLC B 期肝细胞癌的临床试验
总计5782个结果
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Amgen主动,不招人复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | CD20阳性 | I 期弥漫性大 B 细胞淋巴瘤 | II 期弥漫性大 B 细胞淋巴瘤 | III 期弥漫性大 B 细胞淋巴瘤 | IV 期弥漫性大 B 细胞淋巴瘤美国
-
H3 Biomedicine Inc.Eisai Inc.完全的肝脏肿瘤 | 肝细胞癌 | 晚期肝细胞癌 | 肝癌 | 肝癌 | 肝癌法国, 美国, 比利时, 西班牙, 台湾, 大韩民国, 俄罗斯联邦, 加拿大, 意大利, 新加坡, 英国
-
University of ArkansasUniversity of Toronto; University of North Carolina, Chapel Hill; University of Calgary撤销
-
The Methodist Hospital Research InstituteGenentech, Inc.尚未招聘
-
National Taiwan University HospitalNational Cheng-Kung University Hospital; Taichung Veterans General Hospital未知
-
Chang Gung Memorial HospitalMinistry of Science and Technology, Taiwan完全的Translational Research of SOX4 in Hepatocellular Carcinoma
-
University of British Columbia完全的
-
Tianjin Medical University Cancer Institute and...招聘中
-
First Affiliated Hospital of Wenzhou Medical UniversityQilu Hospital of Shandong University; Eastern Hepatobiliary Surgery Hospital; The First Affiliated...邀请报名
-
Cancer Hospital of Guangxi Medical University主动,不招人
-
Merck Sharp & Dohme LLC主动,不招人晚期肝细胞癌美国, 中国, 意大利, 日本, 大韩民国, 波兰, 西班牙, 瑞士, 台湾
-
Eastern Hepatobiliary Surgery Hospital完全的Hepatocellular Carcinoma; | Radical Hepatic Resection;中国
-
National Cancer Institute (NCI)完全的
-
Gerhard TreiberCrolll Gmbh; Janssen Diagnostics, LLC; Estimate, GmbH完全的
-
Universitaire Ziekenhuizen KU LeuvenFund for Scientific Research, Flanders, Belgium未知
-
Qing XIeShanghai MedSci Healthcare Co. Ltd未知
-
SignalRX Pharmaceuticals, Inc.University of California, San Diego终止
-
Daiichi Sankyo, Inc.完全的肝脏肿瘤 | 晚期肝细胞癌 | 肝癌 | 肝癌大韩民国, 台湾, 美国, 日本
-
Second Affiliated Hospital of Guangzhou Medical...招聘中
-
Suzhou Kintor Pharmaceutical Inc,完全的
-
Second Affiliated Hospital, School of Medicine,...招聘中
-
Ludwig-Maximilians - University of Munich招聘中
-
Second Affiliated Hospital of Guangzhou Medical...First People's Hospital of Foshan; Huizhou Municipal Central Hospital; Zhongshan People's Hospital... 和其他合作者完全的
-
University of Michigan Rogel Cancer CenterExelixis主动,不招人